Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

NCT ID: NCT01295463

Last Updated: 2013-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Learning about the amount of information on fertility and infertility by patients before they received treatment for cancer in a comprehensive cancer center may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

Primary

* To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center.

Secondary

* To analyze whether the information received by patients is related to the desire to be parents.
* To analyze whether the information received by patients is related to the desire to be informed.
* To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients.

OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

sexual dysfunction psychosocial effects of cancer and its treatment infertility colon cancer male breast cancer breast cancer germ cell tumor ovarian sarcoma uterine sarcoma chronic lymphocytic leukemia osteosarcoma chronic myelogenous leukemia non-Hodgkin lymphoma adult acute myeloid leukemia with 11q23 (MLL) abnormalities adult acute myeloid leukemia with inv(16)(p13;q22) adult acute myeloid leukemia with t(15;17)(q22;q12) adult acute myeloid leukemia with t(16;16)(p13;q22) adult acute myeloid leukemia with t(8;21)(q22;q22) mast cell leukemia hairy cell leukemia prolymphocytic leukemia adult acute lymphoblastic leukemia adult acute myeloid leukemia adult Hodgkin lymphoma adult T-cell leukemia/lymphoma small intestine lymphoma anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma mycosis fungoides/Sezary syndrome intraocular lymphoma primary central nervous system non-Hodgkin lymphoma primary central nervous system Hodgkin lymphoma noncutaneous extranodal lymphoma secondary acute myeloid leukemia acute undifferentiated leukemia central nervous system leukemia T-cell large granular lymphocyte leukemia atypical chronic myeloid leukemia, BCR-ABL1 negative clear cell sarcoma of the kidney Kaposi sarcoma adult soft tissue sarcoma chronic myelomonocytic leukemia secondary central nervous system Hodgkin lymphoma cutaneous lymphoma adult non-Hodgkin lymphoma

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire administration

Intervention Type OTHER

study of socioeconomic and demographic variables

Intervention Type OTHER

assessment of therapy complications

Intervention Type PROCEDURE

fertility assessment and management

Intervention Type PROCEDURE

psychosocial assessment and care

Intervention Type PROCEDURE

quality-of-life assessment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma

* Free of disease
* Completed treatment within the past 1-2 years

PATIENT CHARACTERISTICS:

* ECOG performance status 0-1
* Must be able to read and self-complete study questionnaires
* No psychological conditions that may prevent participation in the study

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
* No concurrent treatment (hormonal treatment for breast cancer is allowed)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut CatalĂ  d'Oncologia

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Josefina Rivera, RGN, MSN

Role: PRINCIPAL_INVESTIGATOR

Institut CatalĂ  d'Oncologia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Catala D'Oncologia

L'Hospitalet de Llobregat, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Josefina Rivera, RGN, MSN

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDR0000695000

Identifier Type: REGISTRY

Identifier Source: secondary_id

EU-21105

Identifier Type: -

Identifier Source: secondary_id

ICO-FERTI

Identifier Type: -

Identifier Source: org_study_id